Compare TXG & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | NHI |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2019 | 1994 |
| Metric | TXG | NHI |
|---|---|---|
| Price | $34.76 | $70.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $20.25 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 3.1M | 368.7K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | $245,893,000.00 | ★ $375,628,000.00 |
| Revenue This Year | N/A | $15.44 |
| Revenue Next Year | $7.33 | $10.01 |
| P/E Ratio | ★ N/A | $85.81 |
| Revenue Growth | ★ 68.06 | 12.07 |
| 52 Week Low | $10.51 | $67.94 |
| 52 Week High | $35.65 | $91.38 |
| Indicator | TXG | NHI |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 40.83 |
| Support Level | $16.11 | $67.94 |
| Resistance Level | $35.65 | $77.80 |
| Average True Range (ATR) | 2.41 | 1.82 |
| MACD | 0.21 | 0.17 |
| Stochastic Oscillator | 88.10 | 47.70 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.